Showing results (121-130 of 2,686) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|April 17, 2025
The spatiotemporal ecology of Oropouche virus across Latin America: a multidisciplinary, laboratory-based, modelling studyCarlo Fischer, Anna Frühauf, Lucia Inchauste, et al.
The Lancet. Infectious Diseases|April 19, 2025
Maternal mastitis and streptococcal toxic shock syndrome risk from breastfeeding children with scarlet fever: case report and literature reviewSonja Dahmann, Maximilian Kueckelhaus, Philipp Wiebringhaus, et al.
The Lancet. Infectious Diseases|May 3, 2025
Urachal actinomycosis mimicking a urachal adenocarcinoma: case report and systematic reviewCamilo Medina, Valentina Garcia, Andrés Gutiérrez, et al.
The Lancet. Infectious Diseases|March 28, 2025
The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trialAnja Saso, Ebrima Kanteh, David Jeffries, et al.
The Lancet. Infectious Diseases|May 24, 2025
Effect of JYNNEOS vaccination on mpox clinical progression: a case-control studyLauren Granskog, Kayla Saadeh, Kieran Lorenz, et al.
The Lancet. Infectious Diseases|May 18, 2025
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
The Lancet. Infectious Diseases|May 24, 2025
Comparative assessment of immunogenicity and safety of recombinant influenza vaccine in children, adolescents, and adults: results from a phase 3, immunobridging, open-label, non-randomised studyPedro M Folegatti, Stephanie Pepin, Cynthia Tabar, et al.
The Lancet. Infectious Diseases|June 12, 2025
Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trialPrasad S Kulkarni, Khalequ Zaman, Sajjad A Desai, et al.
The Lancet. Infectious Diseases|January 31, 2026
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trialScott K Heysell, Stellah G Mpagama, Edwin Nuwagira, et al.
The Lancet. Infectious Diseases|January 26, 2026
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trialIlse De Coster, Mohammad AbdelGhany, Eleanna Sarakinou, et al.
Pageof 269